Once daily intravenous (IV) busulfan (Bu) containing preparative regimens for hematopoietic stem cell transplantation (HSCT): Low incidence of Hepatic Veno-Occlusive Disease (HVOD) and improved early survival in a single center’s experience
2005 ◽
Vol 11
(2)
◽
pp. 31
2009 ◽
Vol 14
(5)
◽
pp. 618-621
◽
2001 ◽
Vol 27
(9)
◽
pp. 983-988
◽
2010 ◽
Vol 14
(6)
◽
pp. 683-687
◽
2012 ◽
Vol 26
(4)
◽
pp. 511-519
◽
2006 ◽
Vol 54
(2)
◽
pp. S378.6-S379
2012 ◽
Vol 18
(2)
◽
pp. S253
◽
2008 ◽
Vol 30
(1)
◽
pp. 63-65